CA
GBT

Crewe Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Crewe Advisors’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-191
Closed -$13K – 1344
2022
Q3 		$13K Hold
191
– – ﹤0.01% 596
2022
Q2 		$6K Buy
+191
New +$5.59K ﹤0.01% 739

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Crewe Advisors's GBT Position: Q4 2022 in Review

Crewe Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 191 shares — an estimated $13K sold.

Crewe Advisors first reported a position in GBT in Q2 2022 and held it in 2 quarters. The position peaked at $13K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Crewe Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Crewe Advisors sold 191 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $13K.
  • Crewe Advisors first reported a position in Global Blood Therapeutics, Inc. in Q2 2022 and held it in 2 quarters.
  • Crewe Advisors's Global Blood Therapeutics, Inc. position peaked at $13K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Crewe Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.